Skip to main content

Table 4 Odds ratio and 95% confdence interval for coronary collateral growth

From: Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study

Models

MetS

MetS after GEE

OR (95%CI)

P Value

OR (95%CI)

P Value

Model 1

1.690 (1.326–2.155)

 < 0.001

1.690 (1.328–2.152)

 < 0.001

Model 2

1.695 (1.328–2.162)

 < 0.001

1.695 (1.331–2.158)

 < 0.001

Model 3

1.709 (1.338–2.183)

 < 0.001

1.709 (1.340–2.179)

 < 0.001

Model 4

1.765 (1.337–2.331)

 < 0.001

1.765 (1.335–2.333)

 < 0.001

Model 5

1.721 (1.273–2.325)

0.001

1.721 (1.276–2.320)

 < 0.001

Model 6

1.882 (1.185–2.989)

0.007

1.862 (1.093–3.172)

0.022

Model 7

1.892 (1.096–3.268)

0.022

1.892 (1.107–3.236)

0.020

Model 8

1.921 (1.109–3.326)

0.020

1.921 (1.120–3.292)

0.018

  1. Model 1: adjusted for age, sex
  2. Model 2: adjusted for age, sex, heart rate, renal disease, former smoker, current smoker
  3. Model 3: adjusted for age, sex, heart rate, renal disease, former smoker, current smoker, prior myocardial infarction, stroke, history of percutaneous coronary intervention
  4. Model 4: adjusted for age, sex, heart rate, renal disease, former smoker, current smoker, prior myocardial infarction, stroke, history of percutaneous coronary intervention, white blood cell, homocysteine, platelet, creatinine, eGFR, glycated albumin, uric acid
  5. Model 5: adjusted for age, sex, heart rate, renal disease, former smoker, current smoker, prior myocardial infarction, stroke, history of percutaneous coronary intervention, white blood cell, homocysteine, platelet, creatinine, eGFR, glycated albumin, uric acid,ventricular ejection fraction; left ventricular end-diastolic dimension; left ventricular end-systolic dimension;
  6. Model 6: adjusted for elevated body mass index, elevated blood pressure, elevated fasting glucose, reduced high-density lipoprotein cholesterol,elevated triglycerides;
  7. Model 7: adjusted for age, sex, heart rate, renal disease, former smoker, current smoker, prior myocardial infarction, stroke, history of percutaneous coronary intervention, white blood cell, homocysteine, platelet, creatinine, eGFR, glycated albumin, uric acid, ventricular ejection fraction; left ventricular end-diastolic dimension; left ventricular end-systolic dimension elevated,body mass index, elevated blood pressure, elevated fasting glucose, reduced high-density lipoprotein cholesterol, elevated triglycerides
  8. Model 8: adjusted for age, sex, heart rate, renal disease, former smoker, current smoker, prior myocardial infarction, stroke, history of percutaneous coronary intervention, white blood cell, homocysteine, platelet, creatinine, eGFR, glycated albumin, uric acid, ventricular ejection fraction; left ventricular end-diastolic dimension; left ventricular end-systolic dimension elevated, body mass index, elevated blood pressure, elevated fasting glucose, reduced high-density lipoprotein cholesterol, elevated triglycerides, Diuretics, ACE inhibitors/ARBs, β-blockers, CCBs, hypoglycaemic agents
  9. GEE generalized estimating equation, OR odd ratio, MetS metabolic syndrome
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840